Building A Better Drug Portfolio: Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), Amgen, Inc. (AMGN)

Page 1 of 2

When building a drug portfolio, most investors stick to pharmaceutical firms. Since these are generally the largest, most profitable options, it’s easy to see why. However, not including a biotechnology company in the mix is a notable weakness in such an approach. While the biotech industry is filled with small, unprofitable companies, one stands out as a giant and it has a place in every drug portfolio.

Pharmaceutical vs Biotechnology

Drugs are an increasingly important aspect of everyday life. With the aging of the Baby Boomers, drug use is set to increase as a large population of future patients moves into their highest medical use years. Add to this the fact that using drugs to treat an illness, despite the often high cost of the drugs involved, can be cheaper than other options, and the trend toward increased drug use seems certain to continue for years to come.

Merck & Co., Inc. (NYSE:MRK)The next big drug, however, isn’t going to show up out of thin air. That means that companies big and small are going to be looking for it. And there are plenty of ailments to target, as even relatively obscure illnesses can prove profitable niches in the drug space.

There are basically two approaches to finding new drugs. One approach, used by pharmaceutical companies, is to examine chemicals that can be beneficial. The other, used by biotechnology companies, examines naturally occurring biological substances as the basis of the research effort. While both are very similar in nature, requiring large up-front research efforts, clinical testing, and Food and Drug Administration approval, the actual processes involved are vastly different.

The pharmaceutical industry is much more mature than the biotech industry, playing host to some of the largest and most profitable companies around. The biotech industry, meanwhile, is often seen as the Wild West, where companies come and go, often at great cost to investors. However, biotechnology is going to be increasingly important in the future and not having some exposure to the industry would be a major mistake if you are building a drug portfolio.

A Solid Portfolio

Finding a good pharmaceutical company doesn’t take a lot of time. Most of the major players are household names and two, Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE), are members of the Dow 30. A third, more diversified drug company, Johnson & Johnson (NYSE:JNJ), is also a Dow member, though its business lineup includes consumer products and medical devices in addition to drugs.

Both Merck & Co., Inc. (NYSE:MRK) and  Pfizer Inc. (NYSE:PFE) would make great additions to a drug portfolio. Each are large participants with notable industry positions. In fact, Pfizer is the largest drug company in the world. Some of the shared strengths of these giants include massive research teams, effective sales forces, and the ability to expand via both internal efforts and mergers and acquisitions. As discovering new drugs becomes increasingly difficult, that last item has become increasingly important.

Johnson & Johnson, meanwhile, is something of a broader industry play, because of its medical device and consumer products divisions. In fact, it is a relatively late entrant into the drug space. That said, the company has a long history of shifting its business over time with acquisitions. The company’s long-term success is very much tied to the successful execution of such transactions, large and small.

All three of these drug companies face similar threats today. The biggest is the fact that some of their most profitable drugs have already lost patent protection, or will find those protections lost in the near future. While each has a pipeline of new drug candidates, the massive profits of successful drugs can be very hard to replace. Still, any of the three would be a good addition to a drug focused portfolio or to provide drug exposure to a more diversified portfolio.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!